论文部分内容阅读
Private automaker Zhejiang Geely Holding Group Co. Ltd. confirmed on March 3 the acquisition of British electric start-up company Emerald Automotive after a year of negotiations， promising investment of at least $200 million over the next five years for the development of the fledgling company’s vehicles.
“The purchase is part of our technological development of new-energy vehicles，” said Li Shufu， founder and chairman of Geely.
Victor Yang， spokesman for Geely， said the purchase is intended to expand the British electric taxi market first.
This isn’t Geely’s first acquisition in the British market， where demand for new-energy vehicles is outstripping that of other European countries.
In February， Geely paid $18.5 million for 80 percent of Manganese Bronze Holdings Plc.， parent company of the maker of London’s cabs.
IpO on Nasdaq
China’s healthcare services provider iKang Guobin Healthcare Group is aiming to raise up to $150 million in an initial public offering （IPO） on the Nasdaq stock market—the latest Chinese company to attempt a listing in the U.S. market.
The Beijing-based company reported revenue of $134 million in the 2012 fiscal year that ended in March 2013， 43 percent up year on year.
Its net profit rose by 25 percent year on year to$12 million， according to its financial reports.
The company， in which Goldman Sachs Group Inc. and Government of Singapore Investment Corp. both have stakes， has 40 health examination and medical treatment centers in 12 cities in China.
Analysts said iKang Guobin is highly likely to be the first Chinese medical examination provider to be listed on the U.S. market.
“The purchase is part of our technological development of new-energy vehicles，” said Li Shufu， founder and chairman of Geely.
Victor Yang， spokesman for Geely， said the purchase is intended to expand the British electric taxi market first.
This isn’t Geely’s first acquisition in the British market， where demand for new-energy vehicles is outstripping that of other European countries.
In February， Geely paid $18.5 million for 80 percent of Manganese Bronze Holdings Plc.， parent company of the maker of London’s cabs.
IpO on Nasdaq
China’s healthcare services provider iKang Guobin Healthcare Group is aiming to raise up to $150 million in an initial public offering （IPO） on the Nasdaq stock market—the latest Chinese company to attempt a listing in the U.S. market.
The Beijing-based company reported revenue of $134 million in the 2012 fiscal year that ended in March 2013， 43 percent up year on year.
Its net profit rose by 25 percent year on year to$12 million， according to its financial reports.
The company， in which Goldman Sachs Group Inc. and Government of Singapore Investment Corp. both have stakes， has 40 health examination and medical treatment centers in 12 cities in China.
Analysts said iKang Guobin is highly likely to be the first Chinese medical examination provider to be listed on the U.S. market.